BioContact Québec

BioContact Québec

October 05, 2005 09:01 ET

Media Advisory: BioContact Quebec 12th Edition Starts Today

QUEBEC, QUEBEC--(CCNMatthews - Oct. 5, 2005) - The leading Canadian biopharmaceutical partnership symposium, BioContact Quebec 2005 kicks off today in Quebec City with more than 150 top financial, investment and biopharmaceutical companies and 1200 participants from around the world including the United States, Asia and Europe.

OPENING ADDRESS - 1:15pm - 2pm Bal Room

Mary Macdonald, Vice-President, Investment Banking Segment, Canada, Thomson Macdonald, will present the opening address with her analysis of the Canadian biotech sector. Ms. Macdonald's conference will tackle the important question "are the early VC investments starting to pay off?" Her update on the biotech industry is not to be missed!


Also not to be missed is the special International Financing Session. BioContact Quebec will host two panels of leading figures in the US financial community who all share a common interest in expanding their involvement with Canadian companies.

Chaiman: Elie Farah, Montreal International
Moderator: Stephen M. Nagler, TriState Ventures LLC

Venture Capital panel:
Thomas McNearny - Alex Zisson
Proquest Investments - Jay Moorin
Vantage Point Venture Partners - Richard Meadows
Atlas Venture - Paul Pospisil
IBM - Alfredo Boratto

Investment Banking:
Bear Stearns - Nikhil Puri
Punk, Ziegel & Company - Ed Gordon
Equity Capital Markets, HSBC - Jim Rossman
Maxim Group - Anthony Sarkis
Needham & Company LLC - Simon Gill


Hana Biosciences, Inc.
Active Pass Pharmaceuticals Inc.
GangaGen Life Sciences Inc.
ChondroGene Limited
3M Canada - Toronto
Adherex Technologies, Inc.
iCo Therapeutics, Inc.
Gemin X Biotechnologies Inc.
ConjuChem, Inc.
Areta international srl

Aegera Therapeutics Inc.
Insception BioSciences, Inc.
Isotechnika Inc.
Genetics Squared, Inc.
Ethypharm Inc.
CANTEST BioPharma Services
Altachem Pharma Ltd
Inflazyme Pharmaceuticals Ltd.
Bioxel Pharma inc.
Mistral Pharma
NewLab Clinical Research Inc.

Fralex Therapeutics Inc.
Molecular Templates Inc
Diagnocure inc.
QSV Biologics Limited
BioCryst Pharmaceuticals, Inc.
Medicago Inc.
Topigen Pharmaceuticals, Inc.
PharmaGap Inc.
Antares Pharma Inc.
Lácer, S.A.

BioContact Quebec 2005 is a unique opportunity to get the inside scoop on the biopharmaceutical sector. A detailed symposium agenda and a list of all participants are available on BioContact Quebec 2005 website:


A media room will be available throughout the conference. A communications officer will be on-site to help media schedule interviews and meetings.

Contact Information

  • BioContact Quebec 2005
    Anie Perrault
    (514) 258-7629